EVER Pharma Product List
Product Description
EVER Pharma
-
AT
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Categories
EVER Pharma
-
AT
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from EVER Pharma (12)
-
Product Cabazitaxel EVER Pharma: 45mg/4.5ml + 50mg/5ml + 60mg/60ml - Single liquid vial
Cabazitaxel EVER Pharma is provided as a single vial, ready to dilute formulation and is available in vial sizes covering the common range of patient specifi c doses for economy and convenience Cabazitaxel is a third-generation antineoplastic taxane and was the fi rst therapy to show a survival benefi t f... -
Product CDMO: Contract Development
EVER is a leader in pharmaceutical development
Our end-to-end service covers every aspect of pharmaceutical development, from API selection to final process validation and quality assurance, with the highest level of expertise.
With ‘state of the art’ labs in Unterach ... -
Product CDMO: Contract Manufacturing
EVER Pharma is a specialist in the manufacture of complex injectable products such as low oxygen formulations, crystal suspensions and oily solutions. This includes many highly active substances such as narcotics, hormones and cytotoxics.
Our state-of-the-art facility utilizes the latest innovatio... -
Product EVER Pharma: Product Portfolio
Our products include: • Atosiban • Cabazitaxel • Cerbrium • Cerebrolysin • Dacepton/Apomorphine • Dexemedetomidine • Docetaxel • Fulvestrant • MemoProve • Oxytocin • Paclitaxel • Pemetrexed • Tachyben • Terlipressin • Trabectedin • Eribulin -
Product Pemetrexed EVER Pharma
Pemetrexed is an antineoplastic chemotherapy drug. It is used in the treatment of malignant mesothelioma and locally advanced or metastatic nonsquamous non-small cell lung cancer. - Available as a ready to dilute liquid formulation - does not require reconstitution from powder saving time and costs. It can... -
Product Terlipressin EVER Pharma
- Ready to use product - for immediate use without reconstitution - Available in vials - safer and more convenient than ampoules - 5ml and new 10ml presentation covering initial and maintenance dose ranges - Additional indication - for Hepato-renal syndrome type I -
Product Trabectedin EVER Pharma: 0.25mg + 1.0mg - LYO Vial
- Available in 2 presentations – providing greater flexibility and convenience when preparing patient specific doses - All vial sizes come in CytoWrap® – for safer handling and transportation Description: Trabectedin is an antineoplastic chemotherapy drug. It is indicated as a monotherapy for the treatme... -
Product Azacitidine EVER Pharma
Azacitidine is a cytotoxic hypomethylating chemical analogue of cytidine used in the treatment of myelodysplastic syndromes.
Azacitidine EVER Pharma is available in both the standard 100 mg vial size and a new 150 mg vial size aligned to the most common patient doses to minimize waste... -
Product Bortezomib EVER Pharma
Bortezomib is a protease inhibitor indicated for the treatment of progressive or untreated multiple myeloma, and mantle cell lymphoma.
Bortezomib EVER Pharma is provided as a ready to useformulation for subcutaneous injection (SC), and afterdilution for intravenous injection. -
Product Cabazitaxel EVER Pharma
Cabazitaxel is a third-generation antineoplastic taxane and was the fi rst therapy to show a survival benefi t for the treatment of patients with docetaxel-refractory mCRPC.
Cabazitaxel EVER Pharma is provided as a single vial, ready to dilute formulation and is available in vial sizes&nbs... -
Product Dexmedetomidine EVER Pharma
Dexmedetomidine is a highly selective alpha-2 adrenergic receptor notable for its ability to provide sedation without the risk of respiratory depression.
The first Dexmedetomidine in Europe indicated for both ICU and procedural sedation. -
Product Fulvestrant EVER Pharma
The first Fulvestrant in Europe approved for storageat room temperature.
EVER Pharma resources (18)
-
News EVER Pharma gains EU Marketing Authorization for Trabectedin
EVER Pharma announces the EU-wide marketing authorization of Trabectedin (in 0.25MG and 1MG vial sizes) for the treatment of advanced soft tissue sarcoma and ovarian cancer -
Technical Data EVER Pharma: Product list of speciality injectables
EVER Pharma's products include: Atosiban -- 7.5 mg/ml Solution for Injection/InfusionAzacitidine -- 25 mg/ml Powder for Suspension for InjectionCabazitaxel -- 10 mg/ml - Solution for InfusionCerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for InfusionDacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml - Solution for Injection/InfusionDexmedetomidine -- 100 µg/ml - Concentrate for Solution for InfusionDocetaxel -- 20 mg/ml - Concentrate for injectionFulvestrant -- 50 mg/ml - Ready to use pre-filled syringeOxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/InfusionPaclitaxel-- 6 mg/ml - Concentrate for InjectionPemetrexed -- 25 mg/ml - Concentrate for Solution for InfusionTerlipressin -- 0.17 mg/ml - Solution for Injection/Infusion -
News EVER Pharma Expands Operations with Opening of New Manufacturing Facility in Jena, Germany
EVER Pharma Expands Operations with Opening of New Manufacturing Facility in Jena, Germany -
Brochure EVER CDMO: Contract Manufacturing
Contract Manufacturing Overview -
News EVER Pharma Announces Approval of Testosterone Undecanoate in the EU
EVER Pharma has announced the approval of Testosterone Undecanoate in the European Union for the treatment of male hypogonadism. -
Brochure EVER CDMO: Contract Development
Overview on EVER's contract development services -
News EVER Pharma Gained EU-Approval of Testosterone Enantate
EVER Pharma, a fully integrated specialty pharmaceuticals company, is pleased toannounce the approval of Testosterone Enantate in the European Union for thetreatment of male hypogonadism. This condition, characterized by insufficienttestosterone production, affecting up to 10% of men globally and 40% of men aged 45. -
Brochure EVER Pharma - Product List
EVER Pharma's products include: Atosiban -- 7.5 mg/ml Solution for Injection/InfusionAzacitidine -- 25 mg/ml Powder for Suspension for InjectionCabazitaxel -- 10 mg/ml - Solution for InfusionCerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for InfusionDacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml - Solution for Injection/InfusionDexmedetomidine -- 100 µg/ml - Concentrate for Solution for InfusionDocetaxel -- 20 mg/ml - Concentrate for injectionFulvestrant -- 50 mg/ml - Ready to use pre-filled syringeOxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/InfusionPaclitaxel-- 6 mg/ml - Concentrate for InjectionPemetrexed -- 25 mg/ml - Concentrate for Solution for InfusionTerlipressin -- 0.17 mg/ml - Solution for Injection/Infusion -
News EVER Pharma gained EU-Approval for Advanced Cancer Treatment
EVER Pharma, a fully integrated specialty pharmaceuticals company, announced the approval of Eribulin in the European Union. Eribulin is indicated for the treatment of locally advanced or metastatic breast cancer and unresectable liposarcoma.
-
Brochure Cabazitaxel EVER Pharma
45mg/4.5ml + 50mg/5.0ml + 60mg/6ml -
News EVER Pharma receives EU approval for a liquid ready to use Bortezomib formulation
EVER Pharma is pleased to announce EU-wide approval of Bortezomib for the treatment of patients with multiple myeloma and mantle cell lymphoma -
Brochure Trabectedin EVER Pharma
0.25mg + 1mg -
Brochure Fulvestrant EVER Pharma
PFS - 250mg/5ml -
Brochure Dexmedetomidine EVER Pharma
Vials + Ampoules: 200µg/2ml + 400µg/4ml + 1000µg/10ml -
Brochure Terlipressin EVER Pharma
1mg/5ml + 2mg/10ml -
Brochure Atosiban EVER Pharma
6.75mg/0.9ml + 37.5/5ml + 75mg/10ml -
Brochure Bortezomib EVER Pharma
2.5mg/1ml + 3.5mg/1.4ml -
Brochure Pemetrexed EVER Pharma
100mg/4ml + 500mg/20ml + 1000mg/40ml
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance